The Market Access and Pricing Team at Cytokinetics focuses on developing and implementing strategies to ensure patient access to the company’s innovative therapies while maximizing their value in the marketplace. This team collaborates across functions to assess pricing models, negotiate contracts, and navigate the complexities of reimbursement, aiming to effectively communicate the benefits of muscle activators to payers and healthcare providers in both the US and Europe.
David Evans
Senior Director, Pricing And C...
Felix Fermin
Director, Value & Access Strat...
Katia Finck
VP, Head of Market Access Euro...
Louisa Leung
Senior Director, U.s. Value & ...
Robert A. Taylor
Senior Director, Value & Acces...
Sunil Karnawat
VP, Global Value, Access & Dis...
William Frazier
Associate Director, US And Glo...